| 000 | 00989 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513133921.0 | ||
| 264 | 0 | _c19980306 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0195-668X | ||
| 024 | 7 |
_a10.1093/eurheartj/18.suppl_f.28 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaseri, A | |
| 245 | 0 | 0 |
_aTargeting new thrombolytic regimens at specific patient groups: implications for research and cost-containment. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cDec 1997 |
||
| 300 |
_aF28-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCost Control |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aResearch |
| 700 | 1 | _aAndreotti, F | |
| 773 | 0 |
_tEuropean heart journal _gvol. 18 Suppl F _gp. F28-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/18.suppl_f.28 _zAvailable from publisher's website |
| 999 |
_c9416464 _d9416464 |
||